Secondary |
Drug Use For Unknown Indication |
23.4% |
Influenza |
14.8% |
Asthma |
7.0% |
Depression |
7.0% |
Upper Respiratory Tract Inflammation |
7.0% |
Hypertension |
5.5% |
Chronic Obstructive Pulmonary Disease |
4.7% |
Arrhythmia |
3.9% |
Nasopharyngitis |
3.9% |
Cough |
3.1% |
Dehydration |
2.3% |
Gastritis |
2.3% |
Insomnia |
2.3% |
Product Used For Unknown Indication |
2.3% |
Prophylaxis |
2.3% |
Abdominal Discomfort |
1.6% |
Allogenic Bone Marrow Transplantation Therapy |
1.6% |
Benign Prostatic Hyperplasia |
1.6% |
Blood Prolactin Increased |
1.6% |
Dermatitis |
1.6% |
|
Pyrexia |
13.3% |
Abnormal Behaviour |
6.7% |
Daydreaming |
6.7% |
Hallucination |
6.7% |
Hepatic Enzyme Increased |
6.7% |
Platelet Count Decreased |
6.7% |
Rash |
6.7% |
White Blood Cell Count Increased |
6.7% |
Activation Syndrome |
3.3% |
Cardiac Failure Congestive |
3.3% |
Choking |
3.3% |
Delirium |
3.3% |
Drug Eruption |
3.3% |
Dyspnoea |
3.3% |
Hyperaemia |
3.3% |
Interstitial Lung Disease |
3.3% |
Medication Error |
3.3% |
Periportal Sinus Dilatation |
3.3% |
Protein Total Decreased |
3.3% |
Screaming |
3.3% |
|
Concomitant |
Drug Use For Unknown Indication |
14.8% |
Product Used For Unknown Indication |
9.6% |
Depression |
8.8% |
Influenza |
8.0% |
Hypertension |
5.6% |
Insomnia |
5.3% |
Herpes Zoster |
5.0% |
Prophylaxis |
4.8% |
Constipation |
4.3% |
Parkinson's Disease |
4.3% |
Rheumatoid Arthritis |
4.1% |
Breast Cancer |
3.7% |
Asthma |
3.6% |
Anxiety |
3.1% |
Epilepsy |
3.0% |
Vomiting |
2.9% |
Gastritis |
2.6% |
Emphysema |
2.5% |
Osteoporosis |
2.1% |
Bipolar Disorder |
1.8% |
|
Vomiting |
19.0% |
Drug Exposure During Pregnancy |
9.5% |
White Blood Cell Count Increased |
7.0% |
White Blood Cell Count Decreased |
6.5% |
Hallucination |
5.5% |
Renal Failure Acute |
5.5% |
Pyrexia |
4.5% |
Urine Output Decreased |
4.5% |
Hypokalaemia |
4.0% |
Rash |
4.0% |
Loss Of Consciousness |
3.5% |
Pneumonia |
3.5% |
Suicide Attempt |
3.5% |
Tremor |
3.5% |
Hepatic Enzyme Increased |
3.0% |
Renal Impairment |
3.0% |
Delirium |
2.5% |
Hepatic Function Abnormal |
2.5% |
Liver Disorder |
2.5% |
Melaena |
2.5% |
|
Interacting |
Hyperlipidaemia |
66.7% |
Cough |
33.3% |
|
|